As Merck cans another hepatitis C project, can leader Gilead capitalize? These days, hepatitis C isn’t looking like the cash cow market it once was, prompting some of those trailing […]
Looking for insulin rebound, Novo Nordisk wins delayed FDA nod for ultrafast Fiasp For Novo Nordisk and its new fast-acting mealtime insulin, a second try at the FDA gatekeepers was […]
Hopkins teams target mosquito gut bacteria to cut malaria spread Johns Hopkins researchers are modifying the gut microbiome of mosquitoes to reduce the spread of malaria, which could become a […]
Prothena scratches MCAM psoriasis antibody after negative trial Irish biotech Prothena has decided to abandon a T helper cell-targeting drug after it failed to hit the mark in a phase […]
Thiel backs Peptilogics to move antibiotic toward IND Peter Thiel has invested in Peptilogics. The Paypal founder contributed to the $5.5 million series A Peptilogics put together to advance its […]
Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval For the second time in just over six months, there’s a newcomer in the next-generation class of CDK […]
Bring it on, pharma: Finger-pointing at insurers provokes AHIP tweetstorm Call it unintended-but-predictable consequences: Launched this summer, a pharma industry campaign called “Let’s Talk About Cost” highlights the role of […]
Pivotal moments for this year’s Fierce 15 winners After announcing this year’s Fierce 15 winners, we invited their executives to the Drug Development Forum in Boston to discuss some of […]
Pharma’s pricing pledges? Maybe they weren’t such a good idea in the first place, experts say BOSTON—Amid reports this week that AbbVie considered doubling back on this year’s price-cap pledge […]
Biotech researchers chart progress in fighting substance abuse As the opioid crisis broadens by the day, the biotech community is doubling down on its efforts to solve the mystery of […]